XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Conversion To Dual Class Common Stock Structure
Common Stock
Class A Common Stock
Conversion Of Class B To Class A
Common Stock
Class A Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Common Stock
Class B Common Stock
Common Stock
Class B Common Stock
Conversion To Dual Class Common Stock Structure
Common Stock
Class B Common Stock
Conversion Of Class B To Class A
Common Stock
Class B Common Stock
Conversion Of Stock By Selling Stockholder Upon Initial Public Offering
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stockholders' Equity, beginning balance $ (50,457) $ 0 $ 0       $ 0       $ 24,882 $ (75,264) $ (75) $ 0
Convertible Preferred Stock, beginning balance (in shares) at Jan. 31, 2019 65,546,000                          
Convertible Preferred Stock, beginning balance at Jan. 31, 2019 $ 156,969                          
Increase (Decrease) in Temporary Equity [Roll Forward]                            
Series E financing, less issuance costs of $326 (in shares) 14,413,000                          
Series E financing, less issuance costs of $326 $ 268,177                          
Convertible Preferred Stock, ending balance (in shares) at Jan. 31, 2020 79,959,000                          
Convertible Preferred Stock, ending balance at Jan. 31, 2020 $ 425,146                          
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2019   48,483,000 0       0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Conversion of stock (in shares)       (48,483,000) 1,151,000     48,483,000 (1,151,000)          
Issuance of common stock related to vested exercised stock options (in shares) 2,141,000           1,475,000              
Issuance of common stock related to vested exercised stock options $ 743                   743      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)             531,000              
Vesting of early exercised stock options 671                   671      
Stock-based compensation expense 40,872                   40,872      
Foreign currency translation adjustments 4,165                       4,165  
Net loss (130,741)                     (130,741)    
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2020   0 1,151,000       49,338,000              
Stockholders' Equity, ending balance at Jan. 31, 2020 (134,747) $ 0 $ 0       $ 0       67,168 (206,005) 4,090 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stockholders' Equity, beginning balance $ (134,747) $ 0 $ 0       $ 0       67,168 (206,005) 4,090 0
Issuance of common stock upon conversion of preferred stock (in shares) (408,000)                          
Issuance of common stock upon conversion of preferred stock $ (242)                          
Convertible Preferred Stock, ending balance (in shares) at Jan. 31, 2021 79,551,000                          
Convertible Preferred Stock, ending balance at Jan. 31, 2021 $ 424,904                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Repurchase of common stock (in shares)             (20,000)              
Repurchase of common stock (820)                   (820)      
Conversion of stock (in shares)             408,000              
Conversion of stock $ 242                   242      
Issuance of common stock related to vested exercised stock options (in shares) 2,862,000           1,876,000              
Issuance of common stock related to vested exercised stock options $ 5,618                   5,618      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)             866,000              
Vesting of early exercised stock options 2,838                   2,838      
Stock-based compensation expense 111,846                   111,846      
Foreign currency translation adjustments (24,005)                       (24,005)  
Net loss (192,194)                     (192,194)    
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2021   0 1,151,000       52,468,000              
Stockholders' Equity, ending balance at Jan. 31, 2021 (231,222) $ 0 $ 0       $ 0       186,892 (398,199) (19,915) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stockholders' Equity, beginning balance $ (231,222) $ 0 $ 0       $ 0       186,892 (398,199) (19,915) 0
Conversion of convertible preferred stock to Class B common stock upon initial public offering (in shares) (79,551,000)                          
Conversion of convertible preferred stock to Class B common stock upon initial public offering $ (424,904)                          
Convertible Preferred Stock, ending balance (in shares) at Jan. 31, 2022 0                          
Convertible Preferred Stock, ending balance at Jan. 31, 2022 [1] $ 0                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Repurchase of common stock (in shares)             (13,000)              
Repurchase of common stock (590)                   (590)      
Conversion of stock (in shares)         14,550,000 2,500,000 79,551,000   (14,550,000) (2,500,000)        
Conversion of stock $ 424,904                   424,904      
Issuance of common stock related to vested exercised stock options (in shares) 4,789,000           4,118,000              
Issuance of common stock related to vested exercised stock options $ 19,408                   19,408      
Issuance of common stock related to early exercised stock options, net of repurchases (in shares)             574,000              
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs (in shares)     8,940,000                      
Issuance of common stock upon initial public offering, net of underwriting discounts and other offering costs 649,845                   649,845      
Issuance of common stock in connections with business combination, net (in shares)             26,000              
Issuance of common stock in connection with business combination, net 959                   959      
Contingent stock consideration in connection with business combination 1,754                   1,754      
Vesting of early exercised stock options 7,212                   7,212      
Warrant exercised (in shares)             73,000              
Warrant exercised 86                   86      
Stock-based compensation expense 30,009                   30,009      
Foreign currency translation adjustments 28,014                       27,639 375
Capital contributions from noncontrolling interest holders 26,450                         26,450
Net loss (157,560)                     (155,138)   (2,422)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2022   0 27,141,000       119,747,000              
Stockholders' Equity, ending balance at Jan. 31, 2022 799,269 [1] $ 0 $ 0       $ 0       1,320,479 (553,337) 7,724 24,403
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stockholders' Equity, beginning balance $ 799,269 [1] $ 0 $ 0       $ 0       $ 1,320,479 $ (553,337) $ 7,724 $ 24,403
[1] (1) As of January 31, 2022, the consolidated balance sheet includes assets and liabilities of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $17.7 million and $3.7 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 10. Joint Venture and Majority Owned Subsidiary” for further discussion.